Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2009 1
2010 1
2012 3
2013 1
2015 2
2016 5
2017 7
2018 8
2019 5
2020 11
2021 5
2022 1
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for picaut p
Search for Ricaut P instead (1 results)
Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study.
Delgado MR, Tilton A, Carranza-Del Río J, Dursun N, Bonikowski M, Aydin R, Maciag-Tymecka I, Oleszek J, Dabrowski E, Grandoulier AS, Picaut P; Dysport in PUL study group. Delgado MR, et al. Among authors: picaut p. Dev Med Child Neurol. 2021 May;63(5):592-600. doi: 10.1111/dmcn.14733. Epub 2020 Nov 18. Dev Med Child Neurol. 2021. PMID: 33206382 Free PMC article. Clinical Trial.
The Expanding Therapeutic Utility of Botulinum Neurotoxins.
Fonfria E, Maignel J, Lezmi S, Martin V, Splevins A, Shubber S, Kalinichev M, Foster K, Picaut P, Krupp J. Fonfria E, et al. Among authors: picaut p. Toxins (Basel). 2018 May 18;10(5):208. doi: 10.3390/toxins10050208. Toxins (Basel). 2018. PMID: 29783676 Free PMC article. Review.
Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
Wu Y, Fang F, Lai W, Li C, Li L, Liu Q, Lu J, Pang X, Sun J, Shi X, Picaut P, Prygova I, Andriopoulos B, Sun Q. Wu Y, et al. Among authors: picaut p. Aesthetic Plast Surg. 2023 Feb;47(1):351-364. doi: 10.1007/s00266-022-03164-3. Epub 2022 Dec 19. Aesthetic Plast Surg. 2023. PMID: 36536093 Free PMC article. Clinical Trial.
Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
Gracies JM, O'Dell M, Vecchio M, Hedera P, Kocer S, Rudzinska-Bar M, Rubin B, Timerbaeva SL, Lusakowska A, Boyer FC, Grandoulier AS, Vilain C, Picaut P; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group. Gracies JM, et al. Among authors: picaut p. Muscle Nerve. 2018 Feb;57(2):245-254. doi: 10.1002/mus.25721. Epub 2017 Aug 13. Muscle Nerve. 2018. PMID: 28590525 Free PMC article. Clinical Trial.
Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial.
Ascher B, Rzany B, Kestemont P, Hilton S, Heckmann M, Bodokh I, Noah EM, Boineau D, Kerscher M, Volteau M, Le Berre P, Picaut P. Ascher B, et al. Among authors: picaut p. Aesthet Surg J. 2020 Aug 14;40(9):1000-1008. doi: 10.1093/asj/sjz248. Aesthet Surg J. 2020. PMID: 31550352 Free PMC article. Clinical Trial.
Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.
Ascher B, Rzany B, Kestemont P, Hilton S, Heckmann M, Bodokh I, Noah EM, Boineau D, Kerscher M, Volteau M, Le Berre P, Picaut P. Ascher B, et al. Among authors: picaut p. Aesthet Surg J. 2020 Jan 1;40(1):93-104. doi: 10.1093/asj/sjz003. Aesthet Surg J. 2020. PMID: 30893430 Free PMC article. Clinical Trial.
44 results